We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Aspiration Cytology Is a Resource for Molecular Profiling

By LabMedica International staff writers
Posted on 23 Nov 2010
Archived and stained fine needle aspirate smears can be used for clinical molecular diagnosis and profiling. More...


DNA can be extracted from aspirate smears stained with Papanicolau (Pap) and Diff-Quick (DQ) stains that were prepared by technicians in a single laboratory according to standard procedure, mounted with a glass coverslips, and stored at room temperature under typical pathology archive conditions.

In a study performed at the National Cancer Institute, (Bethesda, MD, USA), 57 fine-needle aspiration cytopathology (FNAC) samples were examined for aberration detection on high-resolution comparative genomic hybridization array, DNA methylation, and single nucleotide polymorphism genotyping platforms. The samples were from patients with suspected small cell lung cancer (SCLC), metastatic lymph node cancer, and/or primary lymphoma.

Cellular material is collected by scraping the entire slide with a razor blade; this is facilitated by wetting the slide with a small amount of about 20 µL of lysis buffer, which helps the material form a clump during scraping. The average DNA yield per slide in this study was 7.4 µg (range: 0.1 µg to 27.9 µg). Unequivocal genomic structural aberrations were identified in 44 of 46 malignant smears. Even the degraded archival Pap smear DNA showed similar structural aberrations matched to DQ samples on Agilent array comparative genomic hybridization (Agilent; Santa Clara, CA, USA) and Infinium genotyping (Illumina; San Diego, CA, USA), although with greater background noise.

The authors of the study concluded, "Cytopathology specimens are an excellent potential source of patient materials for clinical molecular profiling, including retrospective genomic analyses and prospective sample collection for individualized therapy or eligibility review for clinical trial enrollment. FNAC samples up to 16 years old yielded copious quantities of genomic DNA suitable for high-resolution genomic and epigenomic profiling". The study was published in November 2010, in the Journal of Molecular Diagnostics.

Related Links:

National Cancer Institute
Agilent
Illumina



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.